Quick Takeaways
- Yuan Xu has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $145,870.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Yuan Xu
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of Yuan Xu is at least $145,870 dollars as of 09 Dec 2025. Yuan Xu is the Director of FATE THERAPEUTICS INC and owns shares of FATE THERAPEUTICS INC (FATE) stock worth about $145.9K.
- Signature
- /s/ Jonathan Young, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Yuan Xu and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: FATE THERAPEUTICS INC ($145,870).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Yuan Xu
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | Director | $145,870 | 29 May 2025 | ||
| AKRO | Akero Therapeutics, Inc. | Director | $0 | 09 Dec 2025 | ||
| XLO | Xilio Therapeutics, Inc. | Director | 11 Jun 2025 |
Insider Transactions Reported by Yuan Xu:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.